F. Gómez-Veiga

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

Matthew R. Smith, Fred Saad, Robert E. Coleman et al. · The Lancet · 2011 · 792 citations · Full text

Urology, Oncology, Genitourinary Cancer +6

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Abdel-Rahmène Azzouzi, S. Vincendeau, Éric Barret et al. · The Lancet Oncology · 2016 · 325 citations · Full text

Urology, Clin1001 Pcm301, Photodynamic Therapy +8

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Andrew J. Armstrong, Arun Azad, Taro Iguchi et al. · Journal of Clinical Oncology · 2022 · 279 citations · Full text

Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry

Simon Chowdhury, Anders Bjartell, Nicolaas Lumen et al. · Targeted Oncology · 2020 · 81 citations · Full text

Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010

J.M. Cózar, B. Miñana, F. Gómez-Veiga et al. · British Journal of Urology · 2012 · 50 citations · Full text